| TSHA Stock Yearly Return 2022 Table | ||||||||||||||||||||||||||||||
TSHA average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare TSHA average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| TSHA Share Performance |
| TSHA Stock Yearly Return 2022 Chart | |||
Also see: • TSHA YTD return • TSHA average annual return 10 years | |||
| About Taysha Gene Therapies Inc |
| Taysha Gene Therapies is a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations. Co. owns the exclusive worldwide rights to a clinical-stage, intrathecally dosed AAV9 gene therapy program, known as TSHA-120, for the treatment of giant axonal neuropathy (GAN). GAN is a rare autosomal recessive disease of the central and peripheral nervous systems caused by loss-of-function gigaxonin gene mutations. TSHA-120 is an AAV9 self-complementary viral vector encoding the full length human gigaxonin protein. The TSHA stock yearly return is shown above.
The yearly return on the TSHA stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2022 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the TSHA annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| TSHA Current Stock Quote |
 Free TSHA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| Taysha Gene Therapies (TSHA) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
TSVT Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!